Navigation Links
Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
Date:10/7/2008

SAN DIEGO, Oct. 7 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that a poster entitled "RDEA119, a Potent and Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran Sulfate Sodium (DSS) -- induced Chronic Colitis in Mice," was presented at the American College of Gastroenterology (ACG) 2008 Annual Meeting in Orlando, Florida. The poster, which provided data from a preclinical study of RDEA119, the Company's lead mitogen-activated ERK kinase (MEK) inhibitor, showed the product candidate to be a promising investigational therapy for inflammatory diseases.

Oral administration of RDEA119 was shown to significantly reduce damage to colonic tissue and disease activity in dextran sulfate sodium (DSS) -- induced chronic colitic mice. The beneficial effect of RDEA119 exceeded that of Remicade(R) (infliximab), the current standard-of-care for the treatment of ulcerative colitis.

"Blocking the MEK1/2 pathway appears to be a promising strategy for treating inflammatory disease, for which a significant unmet medical need still exists," commented Dr. Barry Quart, PharmD, president and chief executive officer. "We are making excellent progress with our programs addressing inflammatory disease and the data presented today demonstrate the potential of our MEK inhibitors, RDEA119 and our second generation MEK inhibitor, RDEA436, as treatments for these diseases, and support our continued efforts in this area."

Earlier this year, the Company successfully completed a Phase 1 study of RDEA119 in healthy volunteers in which the product candidate demonstrated a long half-life and a favorable pharmacokinetic profile. The Company plans to initiate a Phase 1b clinical trial of RDEA119 in gouty arthritis l
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
2. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
3. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
4. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
5. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
6. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
7. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
10. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
11. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- The number of people overdosing from opioid prescription ... percent of the workforce has misused prescription painkillers, according ... making opioid use a serious threat to employee safety. ... correct dosage with a valid prescription, subtle impairment may ... Safety Council released a guide for employers, ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... -- Elekta (NSE:EKTAb) and Royal Philips (NYSE: ... Trust ( Manchester, UK ), a specialist ... to develop the clinical value of an integrated magnetic ... system would, in principle, improve the practice of radiotherapy ... "The Christie was an essential participant in the project ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
... Lilly and Company (NYSE: LLY ) announced ... Lilly to access innovation being developed outside the company,s ... independent venture capital firms participating in the Mirror Portfolio ... stage of their development. The first is a molecule ...
... 2011 Mylan Inc. (Nasdaq: MYL ) ... launched Voriconazole Tablets, 50 mg and 200 mg, under ... Inc. Mylan was the first company to have filed ... for Voriconazole Tablets and was awarded 180 days of ...
Cached Medicine Technology:Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 2Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 3Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 4
(Date:7/22/2014)... Brand journalism tactics for ... Ragan Communications 2014 Health Care PR and Marketing ... consecutive year that MediaSource placed in the finalist category ... the winning MediaSource team last year. This year the ... against three other contenders that include AMF Media Group ...
(Date:7/22/2014)... HealthDay Reporter , MONDAY, July 21, 2014 (HealthDay ... high school may take fewer health risks than their peers ... of low-income Los Angeles teens, found that those who attended ... binge-drink, have multiple sex partners or take certain other health ... kids" being more likely to go to good schools, researchers ...
(Date:7/22/2014)... team has identified protein "signatures" of genetic mutations ... cause of cancer deaths after lung cancer. , ... current issue of the journal Nature ... cancer, "will enable new advances" in diagnosing and ... a first-of-its-kind paper. I think it,s a very ...
(Date:7/22/2014)... July 22, 2014 SkillSurvey Inc., ... that help employers make better hiring decisions, will ... to improve the engagement and retention of contingent ... Recruitment’s IMAGE 2014 Conference being held in Orlando, ... include a case study featuring Metro Health, a ...
(Date:7/22/2014)... 2014 The purpose of this ... specific market segment called disposable medical supplies. Disposable ... global healthcare equipment and supplies sector. The disposable ... syringes, disposable medical catheters, wound care products, isolation ... products, blood glucose test strips, lancets, lancing devices, ...
Breaking Medicine News(10 mins):Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 2Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 3Health News:Good Schools May Be Good for a Teen's Health, Too 2Health News:Good Schools May Be Good for a Teen's Health, Too 3Health News:Vanderbilt discovery may advance colorectal cancer diagnosis and treatment 2Health News:SkillSurvey to Present Research on Contingent Workers at National Association for Health Care Recruitment IMAGE 2014 Conference 2Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 2Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 3Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 4Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 5
... areas of B.C. are up to twice as likely ... better-off areas, a University of British Columbia study has ... online journal Public Library of Science ONE , ... are more vulnerable to death from chronic disease, particularly ...
... N.Y., Jan. 8 Davis Vision, Inc., headquartered in ... of sales for its Northern division. In this new ... Davis Vision,s national new business development. "Mike will be ... said Tom Davis, Davis Vision,s executive vice president and ...
... Supplement Health and Education Act Mandates Label ... , WASHINGTON, Jan. 8 In response ... supplement regulation, the Natural Products Association,s Executive ... statement:Increased scrutiny by professional sports leagues on ...
... illness can lead to poorer quality of lifeparticularly ... help teens cope with their conditions. , Two ... professor of medicine, and Sian Cotton, PhD, research ... investigated how adolescents with inflammatory bowel disease (IBD)a ...
... on pets during National Glaucoma month. , ... Tampa, ... Month, Florida Veterinary Specialists (FVS) are spreading the word ... as humans.    , , ,"When eyes go bad, they often do so ...
... much more likely to be deadly for women and African-Americans, ... for only part of the differences for such patients compared ... in the Jan. 1 issue of the journal Cancer ... If age, tumor type, and stage of the disease upon ...
Cached Medicine News:Health News:Mortality rates higher for heart disease patients in poorer B.C. neighborhoods 2Health News:Davis Vision, Inc. Names Michael Ehrle Divisional Vice President of Sales 2Health News:Natural Products Association Advocates Strength of Dietary Supplement Law 2Health News:Spirituality may help adolescents cope with chronic illness 2Health News:Spirituality may help adolescents cope with chronic illness 3Health News:Glaucoma Awareness Not Just for Humans 2Health News:Glaucoma Awareness Not Just for Humans 3Health News:Why Bladder Cancer Is Deadlier for Some 2Health News:Why Bladder Cancer Is Deadlier for Some 3Health News:Why Bladder Cancer Is Deadlier for Some 4
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
96-Well PCR Plate Sealing Mat...
Inquire...
Inquire...
Medicine Products: